HIBODY Trademark

Trademark Overview


On Wednesday, April 7, 2021, a trademark application was filed for HIBODY with the United States Patent and Trademark Office. The USPTO has given the HIBODY trademark a serial number of 79319682. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, July 19, 2022. This trademark is owned by RemeGen Co., Ltd.. The HIBODY trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Human drug; biochemical drug; anticancer drug formulations; biological agents for the treatment of cancer; pharmaceuticals used to treat cancer; medical immunoassay reagent preparations; a medicinal preparation used to treat diseases and disorders related to the immune system; chemical drug formulation; medical drug; biological preparations for medical purposes

Drug testing

Biological research and analysis; drug research service; biochemistry research and analysis; technical research; biological research; clinical trials; development of pharmaceutical preparations and medicines; implement early evaluation in the field of biomedical research services
hibody

General Information


Serial Number79319682
Word MarkHIBODY
Filing DateWednesday, April 7, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, July 19, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkTrademarks have no meaning, do not mean geographical names, and have no special meaning in related product or service industries.
Goods and ServicesHuman drug; biochemical drug; anticancer drug formulations; biological agents for the treatment of cancer; pharmaceuticals used to treat cancer; medical immunoassay reagent preparations; a medicinal preparation used to treat diseases and disorders related to the immune system; chemical drug formulation; medical drug; biological preparations for medical purposes
Pseudo MarkHI BODY
Goods and ServicesDrug testing
Goods and ServicesBiological research and analysis; drug research service; biochemistry research and analysis; technical research; biological research; clinical trials; development of pharmaceutical preparations and medicines; implement early evaluation in the field of biomedical research services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 13, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 30, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRemeGen Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Monday, August 7, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 19, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 19, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, April 23, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, April 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, July 19, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, July 19, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, July 19, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, January 15, 2022REFUSAL PROCESSED BY IB
Monday, December 27, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, December 27, 2021REFUSAL PROCESSED BY MPU
Wednesday, December 1, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 30, 2021NON-FINAL ACTION WRITTEN
Tuesday, November 30, 2021NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Tuesday, November 30, 2021CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Tuesday, November 30, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, November 29, 2021NON-FINAL ACTION WRITTEN
Wednesday, November 24, 2021ASSIGNED TO EXAMINER
Monday, November 8, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Friday, September 17, 2021APPLICATION FILING RECEIPT MAILED
Monday, September 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 9, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB